Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Residual Scope: Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Kasarskis, Edward
(PI)
Neurology
Overview
Fingerprint
Projects & Grants
(1)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Memantine
100%
Treatment of Amyotrophic Lateral Sclerosis
100%
Amyotrophic Lateral Sclerosis
100%
Riluzole
20%
Cognitive Disorders
10%
Frontotemporal Dementia
10%
Neurodegenerative Disorder
10%
Cognitive Change
10%
Complement Component C3
10%
Placebo
10%
Neurofilament
10%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Memantine
100%
Disease Exacerbation
45%
Riluzole
18%
Drug Screening
9%
Biological Marker
9%
Cognitive Defect
9%
Placebo
9%
Complement Component C3
9%
Frontotemporal Dementia
9%
Degenerative Disease
9%
Combination Therapy
9%